Skip Navigation


Japanese Journal of Clinical Oncology Advance Access originally published online on September 25, 2006
Japanese Journal of Clinical Oncology 2006 36(11):735-738; doi:10.1093/jjco/hyl087
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
36/11/735    most recent
hyl087v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ishiguro, S.
Right arrow Articles by Moriya, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishiguro, S.
Right arrow Articles by Moriya, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2006 Foundation for Promotion of Cancer Research

A Case of Resected Huge Ileocolonic Mesenteric Liposarcoma which Responded to Pre-operative Chemotherapy using Doxorubicin, Cisplatin and Ifosfamide

Seiji Ishiguro, Seiichiro Yamamoto, Hirokazu Chuman and Yoshihiro Moriya

Colorectal Surgery Division, National Cancer Center Hospital, Tokyo, Japan

For reprints and all correspondence: Seiichiro Yamamoto, Colorectal Surgery Division, National Cancer Center Hospital, 5-1-1 Tsukiji Tyuo-ku, Tokyo 104-0045, Japan. E-mail: sishigur{at}ncc.go.jp

Received February 13, 2006; accepted June 15, 2006

Primary mesenteric liposarcoma is a rare entity that has been reported only 14 times in English literature. The treatment strategy for mesenteric liposarcoma is, if no distant metastases are detected, surgical resection with a wide surgical margin, often followed by radiation and/or adjuvant chemotherapy for high-risk patients. However, the efficacy of pre-operative chemotherapy is unknown. If the tumor is shrunk by pre-operative chemotherapy, we could achieve complete surgical resection, which is difficult when the tumor is too large or is invading neighboring organs. We herein describe a case of huge mesenteric liposarcoma that showed significant tumor shrinkage by pre-operative chemotherapy using doxorubicin, cisplatin and ifosfamide, allowing a margin-negative operation.

Key Words: mesenteric liposarcoma • preoperative chemotherapy • doxorubicin • ifosfamide


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.